Premium Information is available for this item - Upgrade for $1 a day
5985-01-235-0905
Directional Coupler
5985012350905 012350905 NB172B
An item specifically designed to be inserted into a transmission line, waveguide or coaxial transmission line to provide a suitable test outlet. The test signal is attenuated to a predetermined value. View more Directional Coupler
November 2023
7
Marketplace 5985-01-235-0905
Request a Quotation from participating marketplace vendors
Related Documents 5985-01-235-0905 1+ Documents (More...)
Restrictions 5985-01-235-0905
5985-01-235-0905 is a Directional Coupler that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. The precious metals content of this item is unknown.
End Users 5985-01-235-0905
- Denmark (ZS01)
- Effective Date:
- 1 Apr 1991
Approved Sources 5985-01-235-0905
- Part Number
- Manufacturer
- Status
- NB172B
- Manufacturer
- 00341 - Lexan Industries, Inc (Obsolete)
- Primary Buy
- Primary Buy
Datasheet 5985-01-235-0905
- Characteristic
- Specifications
- Design Type [APGF]
- Specifications
- Bidirectional
- Power Loss In Decibels [BGPX]
- 26.0
- Radio Frequency Rating [ANKZ]
- 7.050 Gigahertz Minimum And 10.000 Gigahertz Maximum
- Overall Length [ABHP]
- 14.000 Inches Nominal
- Unit Type [APQB]
- Waveguide
- Terminal Fitting Name [BGPY]
- Type N Female
NATO Stock Numbers Related to 5985-01-235-0905
Freight Information 5985-01-235-0905
5985-01-235-0905 has freight characteristics managed by Denmark.. 5985-01-235-0905 has a variance between NMFC and UFC when transported by rail and the description should be consulted.